Picture of OliPass logo

244460 OliPass Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-2.55%
3m+1.16%
6m-38.14%
1yr-74.46%
Volume Change (%)
10d/3m-83.3%
Price vs... (%)
52w High-85.51%
50d MA-1.76%
200d MA-55.5%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-164.19%
Return on Equity-858.08%
Operating Margin-354.54%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of OliPass EPS forecast chart

Profile Summary

OliPass Corporation is a Korea-based company principally engaged in the research and development of bio medicine. The Company principally manufactures and sells nonopioid analgesic, hyperlipidemia medicine, ocular angiogenesis inhibitor, duchenne dystrophy medicine, cancer immunotherapy medicine and other products. In addition, the Company researches, develops and sells functional cosmetics through the artificial gene platform technology.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
November 16th, 2006
Public Since
September 20th, 2019
No. of Shareholders
15,695
No. of Employees
70
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KOSDAQ
Shares in Issue
31,238,160
Blurred out image of a map
Address
4th Floor, YONGIN, 17015
Web
https://www.olipass.com
Phone
+82 264882200
Auditors
Hanwool Accounting

244460 Share Price Performance

Upcoming Events for 244460

OliPass Corp Extraordinary Shareholders Meeting

Similar to 244460

Picture of ABion logo

ABion

kr flag iconKorea Exchange - KOSDAQ

Picture of ABL Bio logo

ABL Bio

kr flag iconKorea Exchange - KOSDAQ

Picture of ADM Korea logo

ADM Korea

kr flag iconKorea Exchange - KOSDAQ

Picture of Amicogen logo

Amicogen

kr flag iconKorea Exchange - KOSDAQ

Picture of AprilBio Co logo

AprilBio Co

kr flag iconKorea Exchange - KOSDAQ

FAQ

0